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Acute Pulmonary Embolism
To the Editor: In their review article, Agnelli 
and Becattini (July 15 issue)1 discuss many im-
portant topics in acute pulmonary embolism. We 
would like to highlight the importance of the use 
of pulmonary magnetic resonance imaging (MRI) 
in the diagnosis of this condition, since substan-
tial technical developments have been introduced 
in recent years.2,3 Continued improvements in-
clude the use of parallel imaging, angiography 
technique, and pulmonary perfusion,2-4 with the 
latter showing the most promise for the diagno-
sis of pulmonary embolism.3 However, even in 
protocols without pulmonary perfusion, large 
studies have shown good results with the use of 
MRI.5 Overall, the combined MRI protocol was 
both reliable and sensitive, with results similar 
to those obtained with 16-slice multidetector 
computed tomography (CT).3 MRI has potential 
advantages over CT, including a radiation-free 
method, a better safety profile for contrast mate-
rial, and capability of functional imaging.4 MRI 
might therefore be considered as a valuable alter-
native in the assessment of suspected pulmonary 
embolism in certain groups of patients.
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To the Editor: Agnelli and Becattini suggest 
that ventilation–perfusion lung scanning should 
be limited to situations in which multidetector CT 
is either unavailable or contraindicated. However, 
nuclear medicine technology has evolved since 
the era of the original Prospective Investigation of 
Pulmonary Embolism Diagnosis (PIOPED) study, 
with advances such as multidetector scanners, 
three-dimensional imaging (including single-
photon-emission CT [SPECT]), improved soft-
ware, hybrid SPECT–CT devices, and better venti-
lation agents (with the latter now available in 
many countries although, notably, not in the 
United States). The authors cite data relevant to 
planar ventilation–perfusion imaging, a technique 
long superseded by SPECT in many centers in 
Europe, Canada, and Australia because of its in-
creased sensitivity, specificity, and reproducibili-
ty and its low nondiagnostic rate.1 Studies have 
consistently suggested a higher sensitivity for 
ventilation–perfusion SPECT (>95%) than multi-
detector CT (68 to 86%),2,3 although prospective 
multicenter trials have yet to be conducted.4 Ven-
tilation–perfusion scintigraphy with the use of 
modern techniques, such as SPECT, has several 
advantages over multidetector CT,2 including a 
higher sensitivity, a lower dose of radiation to the 
breast, a lower risk associated with contrast ma-
terial, and a greater number of technically ade-
quate studies. Thus, the use of this technology 
should be part of the imaging algorithm for the 
diagnosis of pulmonary embolism today.
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To the Editor: We have a different opinion re-
garding the need for ventilation–perfusion scan-
ning or CT in patients with a high clinical suspi-
cion of pulmonary embolism who are undergoing 
positive duplex ultrasonography of the lower 
limbs. The authors conclude that no further lung 
imaging for definitive diagnosis of suspected 
pulmonary embolism is necessary in such patients 
and that practitioners should proceed directly to 
anticoagulation. The difficulty arises when this 
same patient presents at a later date with a pos-
sibly new embolus. One must establish whether 
this episode represents a recurrent lung embo-
lism or a nonembolic respiratory problem. We 
agree with the suggestion of Fedullo and Tapson1 
that lung imaging at the time of the first presen-
tation would answer this question. The use of 
such imaging would obviate the need for lifelong 
anticoagulation in case a recurrent embolus is 
ruled out.
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To the Editor: Agnelli and Becattini recom-
mend a strategy of clinical-probability assess-
ment, d-dimer testing, and (if necessary) multi-
detector CT for patients whose condition is 
hemodynamically stable and who have a low 
clinical probability of pulmonary embolism. For 
patients in this category who have none of the 
Pulmonary Embolism Rule-out Criteria (PERC), 
further diagnostic testing may be avoided.1 The 
PERC rule (age, <50 years; pulse, <100 bpm; oxy-
gen saturation, ≥95%; and no unilateral leg swell-
ing, hemoptysis, recent surgery, hormone use, or 
previous venous thromboembolism) has been 
prospectively validated with a sensitivity of 97.4% 
in patients at very low risk.2 The d-dimer assay 
may be falsely positive in a variety of conditions 
other than pulmonary embolism,3 leading to un-
necessary CT imaging. Given the importance of 
reducing morbidity, mortality, and financial costs 
from unnecessary radiation exposure, as illus-
trated by the 2010 Food and Drug Administra-
tion initiative,4 the PERC rule warrants consider-
ation in the evaluation of pulmonary embolism 
in patients with hemodynamic stability and a low 
clinical probability of pulmonary embolism.
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To the Editor: We are surprised that Agnelli 
and Becattini do not mention the role of electro-
cardiography in the diagnosis of pulmonary em-
bolism. Even in the era of sophisticated proce-
dures, electrocardiography probably remains the 
first technical investigation undertaken in patients 
with symptoms of pulmonary embolism, in par-
ticular when presenting with chest pain. Distinct 
electrocardiographic signs, although limited in 
the diagnostic workup, have clearly been associ-
ated with right ventricular strain and dysfunc-
tion. Anterior T-wave inversion was found to be 
associated with increased mean pulmonary arte-
rial pressure,1 and the development of QR in V1 
was identified as an independent risk factor for 
an adverse prognosis.2 In clinical practice, the 
presence of these signs may push toward an ag-
gressive approach and shorten the time to intra-
vascular thrombolysis. Electrocardiography still 
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has value in the management of acute pulmonary 
embolism, in particular in risk stratification.
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To the Editor: Agnelli and Becattini state that 
“surgical embolectomy should be restricted to 
high-risk patients with an absolute contraindica-
tion to thrombolytic treatment and those in whom 
thrombolytic treatment has not improved hemo-
dynamic status.” We strongly disagree. Studies 
have suggested that surgical pulmonary embo-
lectomy should also be considered early in the 
management of acute, massive pulmonary em-
bolus in hemodynamically stable patients with 
right ventricular dysfunction who have large cen-
tral clots involving the main pulmonary artery 
and its branches. Operative mortality in such pa-
tients is 6 to 8%.1,2 In contrast, patients who 
have sustained a cardiac arrest, who require car-
diopulmonary resuscitation or high-dose ino-
tropes, or who have multisystem failure have 
rates of death of more than 50%.3 Retrospective 
studies have shown that thrombolytic therapy re-
sults in a higher rate of death, an increased risk 
of major hemorrhage, and a higher recurrence 
rate of pulmonary embolism than does surgical 
embolectomy.4 Surgical embolectomy is an effec-
tive therapeutic option for the treatment of acute, 
massive pulmonary embolism, and under the 
proper circumstances, it should be considered 
first-line therapy, not the last resort.
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The authors reply: Hochhegger et al. assert 
that recent technical developments in pulmonary 
MRI qualify this procedure for an upgrade in the 
diagnostic algorithms of pulmonary embolism. 
This change would be particularly welcome in 
light of potential safety advantages of MRI over 
multidetector CT. However, whether these im-
provements would result in a clinical advantage 
needs to be assessed in large-scale, prospective 
studies.1 These considerations also apply to ven-
tilation–perfusion SPECT, which can improve the 
performance of the traditional planar ventilation–
perfusion imaging,2 as noted by Roach and Bajc. 
Both MRI and ventilation–perfusion SPECT share 
the challenge of requiring around-the-clock avail-
ability in hospitals.
Whether patients with proven proximal deep-
vein thrombosis should proceed to further test-
ing to confirm suspected pulmonary embolism, 
as suggested by Sfedu et al., is a common clini-
cal discussion. Indeed, although lung imaging 
may facilitate risk stratification and patient fol-
low-up, it will not change treatment in a large 
majority of patients.3
Rosenson supports the PERC rule to avoid 
d-dimer testing and CT to exclude pulmonary 
embolism in hemodynamically stable patients 
with low clinical probability. This approach might 
be considered in patients with definitively low 
clinical probability, keeping in mind that it has 
not been validated in management studies.
Huber and Müller question the limited role 
that we assigned to electrocardiography in the 
treatment of patients with acute pulmonary em-
bolism. They are correct in that electrocardiog-
raphy is crucial in patients presenting with chest 
pain or dyspnea and could be incorporated into 
the assessment of the clinical probability of pul-
monary embolism. However, electrocardiography 
needs to be followed by additional testing for 
diagnosis, as well for risk stratification for an 
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adverse outcome. Indeed, to our knowledge, no 
intervention study has been performed to evalu-
ate the clinical benefit of more aggressive man-
agement of acute pulmonary embolism on the 
basis of electrocardiographic findings.
Lazar and Farber propose to extend surgical 
embolectomy to hemodynamically stable patients 
who are at moderately high risk for pulmonary 
embolism. They also express concern about the 
increased risk of bleeding associated with throm-
bolytic therapy. A large, randomized trial, the 
Pulmonary Embolism International Thrombolysis 
Study (ClinicalTrials.gov number, NCT00639743), 
is ongoing to explore the clinical benefit of 
thrombolysis in such patients. A similar prospec-
tive study should be performed with respect to 
surgical embolectomy for acute pulmonary em-
bolism before that approach can be considered 
as a first-line therapy rather than as a procedure 
for selected patients in selected medical institu-
tions by experienced surgical teams.
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Accountability Measures to Promote Quality Improvement
To the Editor: Chassin et al. (Aug. 12 issue)1 
describe the recent history of accountability mea-
sures in hospitals, which, they argue, promote 
quality improvement. But measurement for the 
purpose of accountability or judgment and mea-
surement for the purpose of improvement of 
health care processes are two very different 
things.2 Properly understood, the two approach-
es can play complementary roles in advancing 
organizational goals. However, confusing mea-
surement for accountability with measurement 
for improvement can only give rise to organiza-
tional confusion and frustration.
First, measurement does not, as implied in 
this article, equate with improvement. Improve-
ment requires making changes to health care 
processes and structures. Second, measurement 
for improvement is not focused on judging wheth-
er data meet a compliance threshold or target. 
Instead it is directed toward determining wheth-
er the changes we make to improve something 
work and to what degree they work. Further-
more, quality improvement incorporates sets of 
related measures (process, outcome, and balanc-
ing) to help us understand the broader effect of 
the changes tested.
Without clearly differentiating measurement 
for accountability from measurement for im-
provement, health care professionals could easily 
confuse the ends with the means.
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The authors reply: We agree with Perla et al. 
that measures used for accountability, such as 
those used in public reporting, accreditation, or 
pay for performance, can differ from measures 
used for local improvement. But the two must be 
closely aligned if the measures used by account-
ability programs are to stimulate the kinds of 
process-improvement activities that lead directly 
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